Bone Biologics (BBLG) Accumulated Depreciation (2014 - 2017)
Bone Biologics (BBLG) reported Accumulated Depreciation of $357.0 for Q4 2017, up 36.78% year-over-year from $261.0 in Q4 2016, and up 7.21% quarter-over-quarter from $333.0 in Q3 2017.
Bone Biologics (BBLG) Accumulated Depreciation (2014 - 2017) Analysis & Trends
Bone Biologics (BBLG) has 4 years of Accumulated Depreciation data on file, last reported at $357.0 in Q4 2017.
- Accumulated Depreciation for Q4 2017 came in at $357.0, up 36.78% year-over-year; the trailing twelve-month figure through Dec 2017 was $357.0 (up 36.78% YoY), and the FY2017 annual result was $357.0, up 36.78% from the prior year.
- Accumulated Depreciation grew to $357.0 in Q4 2017 per BBLG's latest filing, from $333.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $3982.0 in Q4 2015 and troughed at $141.0 in Q1 2016.
- A 4-year average of $816.54 and a median of $309.0 in 2017 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2015 and 2016: Accumulated Depreciation jumped 1322.14% in 2015, then plunged 93.45% in 2016.
- A 4-year view of Accumulated Depreciation shows it stood at $280.0 in 2014, then jumped by 1322.14% to $3982.0 in 2015, then sank by 93.45% to $261.0 in 2016, then soared by 36.78% to $357.0 in 2017.
- Business Quant data shows BBLG's Accumulated Depreciation at $357.0 in Q4 2017, $333.0 in Q3 2017, and $309.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 357.00 |
| Sep 30, 2017 | 333.00 |
| Jun 30, 2017 | 309.00 |
| Mar 31, 2017 | 285.00 |
| Dec 31, 2016 | 261.00 |
| Sep 30, 2016 | 221.00 |
| Jun 30, 2016 | 181.00 |
| Mar 31, 2016 | 141.00 |
| Dec 31, 2015 | 3,982.00 |
| Sep 30, 2015 | 1,992.00 |
| Jun 30, 2015 | 1,422.00 |
| Mar 31, 2015 | 851.00 |
| Dec 31, 2014 | 280.00 |